Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.
Frontiers in cardiovascular medicine（2022）
摘要
Our study suggested that sacubitril/valsartan treatment in MHD patients with HFpEF was effective and safe.
更多查看译文
关键词
heart failure with preserved ejection fraction,hemodialysis,left ventricle dysfunction,pulmonary hypertension,sacubitril/valsartan
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要